USFDA concludes inspection at Alembic Pharmaceuticals’ Gujarat API-I & II facility

02 Jun 2025 Evaluate

United States Food and Drug Administration (USFDA) has concluded an inspection at Alembic Pharmaceuticals’ API-I & II facility located at Panelav, Gujarat. The inspection was conducted from May 26, 2025 to May 31, 2025. This was an un-announced and routine cGMP inspection. The USFDA issued a Form 483 with four observations. None of the observations are related to data integrity and management believes that they are addressable.

The company will provide comprehensive response to USFDA for the observations within the stipulated period. The company is committed to maintain the highest quality standards and compliance at all times.

Alembic Pharmaceuticals is principally engaged in the manufacturing and selling of pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.

Alembic Pharma Share Price

899.90 -2.30 (-0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×